<font color="blue">[_1</font> <font color="blue">Improving_1</font> <font color="blue">wound_2</font> <font color="blue">healing_2</font> after nose surgery by combined administration of xylometazoline and dexpanthenol ] . 
<br>
<br> BACKGROUND The <font color="blue">aim_1</font> of this study was the <font color="blue">examination_1</font> <font color="blue">of_1</font> <font color="blue">efficacy_2</font> <font color="blue">and_2</font> <font color="blue">tolerability_2</font> of an application - form of the new combination of Xylometazoline with Dexpanthenol ( Nasic ) versus Xylometazoline alone . 
<br> PATIENTS AND METHODS Randomized verum controlled parallel - group - comparison of two weeks treatment of a nasal - spray . 61 inpatients with the diagnosis Rhinitis following nasal operation were included in this study and 30 patients were treated with verum and placebo each . The <font color="blue">assessment_1</font> <font color="blue">of_1</font> <font color="blue">nasal_1</font> <font color="blue">-_1</font> <font color="blue">breathing_1</font> <font color="blue">-_1</font> <font color="blue">resistance_1</font> <font color="blue">according_1</font> <font color="blue">to_1</font> <font color="blue">scores_1</font> was defined as <font color="blue">target_1</font> <font color="blue">-_1</font> <font color="blue">parameter_1</font> . <font color="blue">Confirmatory_1</font> <font color="blue">statistical_1</font> <font color="blue">analysis_1</font> was carried out according to <font color="blue">Wilcoxon_1</font> <font color="blue">-_1</font> <font color="blue">Mann_1</font> <font color="blue">-_1</font> <font color="blue">Whitney_1</font> <font color="blue">-_1</font> <font color="blue">U_1</font> <font color="blue">two_1</font> <font color="blue">-_1</font> <font color="blue">sided_1</font> <font color="blue">at_1</font> <font color="blue">alpha_1</font> < or = 0.05 . 
<br> MAIN <font color="blue">OUTCOME_1</font> <font color="blue">MEASURE_1</font> The <font color="blue">superiority_2</font> <font color="blue">of_1</font> <font color="blue">the_1</font> <font color="blue">combination_1</font> <font color="blue">of_1</font> <font color="blue">Xylometazoline_1</font> <font color="blue">-_1</font> <font color="blue">Dexpanthenol_1</font> <font color="blue">nasal_1</font> <font color="blue">-_1</font> <font color="blue">spray_1</font> <font color="blue">versus_1</font> <font color="blue">Xylometazoline_1</font> <font color="blue">nasal_1</font> <font color="blue">spray_1</font> could be proven for the <font color="blue">target_1</font> <font color="blue">-_1</font> <font color="blue">parameter_1</font> as <font color="blue">clinically_1</font> <font color="blue">relevant_1</font> and <font color="blue">statistically_1</font> <font color="blue">significant_1</font> <font color="blue">._1</font> The <font color="blue">clinically_1</font> <font color="blue">proven_1</font> <font color="blue">efficacy_1</font> is emphasized by <font color="blue">good_2</font> <font color="blue">tolerability_2</font> of both treatments . Due to easy handling of the nasal - spray a <font color="blue">good_1</font> <font color="blue">compliance_1</font> was <font color="blue">confirmed_1</font> <font color="blue">._1</font> 
<br> CONCLUSION <font color="blue">Distinct_2</font> <font color="blue">improvement_2</font> <font color="blue">of_2</font> <font color="blue">symptoms_2</font> in patients following nasal operations underlines the <font color="blue">efficacy_1</font> of both medications . With respect to the tolerability therapy with the combination is <font color="blue">more_1</font> <font color="blue">beneficial_1</font> in <font color="blue">comparison_1</font> to the alternative therapy . The <font color="blue">result_1</font> of this controlled clinical study confirms that the combination Xylometazoline - Dexpanthenol is an <font color="blue">enlargement_2</font> <font color="blue">and_2</font> <font color="blue">improvement_2</font> <font color="blue">of_2</font> <font color="blue">effective_2</font> <font color="blue">medicinal_1</font> <font color="blue">treatment_1</font> <font color="blue">of_1</font> <font color="blue">rhinitis_1</font> following nasal operation in <font color="blue">comparison_1</font> to therapy with Xylometazoline alone .